Liver Cancer

Modeling Agent

Antiviral Infection ^[1]

HBV

OSS_128167

Emtricitabine

Azvudine

Bicyclol

Morphothiadin

JNJ-632

2',3'-Dideoxyadenosine

Bay 41-4109 racemate

HCV

AG-1478

Mizoribine

Sofosbuvir

Telaprevir

Danoprevir

Boceprevir

Daclatasvir

Lomibuvir

NCCN Guidelines Recommendations ^[2]

First-Line Systemic Therapy

Atezolizumab

Bevacizumab

Sorafenib

Lenvatinib

Durvalumab

Pembrolizumab

Subsequent-Line Systemic Therapy

Regorafenib

Cabozantinib

Ramucirumab

Lenvatinib

Nivolumab

Sorafenib

Ipilimumab

Pembrolizumab

Dostarlimab

FOLFOX4 Regiment

5-FU

Folinic acid

Oxaliplatin

Inhibitors

Linifanib

Tivantinib

Axitinib

Apatinib

Chemotherapy

Platinum-based

Cisplatin

Carboplatin

Nedaplatin

Oxaliplatin

Alkaloids

Paclitaxel

Nab-Paclitaxel

Docetaxel

Antimetabolites

Pemetrexed

Gemcitabine

5-FU

Folinic acid

TOPO Inhibitors

Irinotecan

Etoposide

Topotecan

Doxorubicin

Epirubicin HCl

Alkylating Agents

Mitomycin C

Cyclophosphamide

Ifosfamide

TMZ

Immune Checkpoint Inhibitors

PD-1

Pembrolizumab

Dostarlimab

Cemiplimab

Camrelizumab

Sintilimab

Nivolumab

Serplulimab

PD-L1

Atezolizumab

Durvalumab

Avelumab

Adebrelimab

Sugemalimab

CTLA-4

Nurulimab

Zalifrelimab

Quavonlimab

Ipilimumab

Tremelimumab

Anti-Angiogenesis

FGFR

Sorafenib

Ponatinib

Infigratinib

Nintedanib

Fexagratinib

FLT3

Pexidartinib

Crenolanib

Foretinib

UNC2025 HCl

Fedratinib

Src

Src Inhibitor 1

WH-4-023

Saracatinib

Bosutinib

Dasatinib

Syk

R406

R406

PRT062607 (P505-15) HCl

Entospletinib

Piceatannol

Mutated Genes-Targeted ^{[3] [4]}

Beta-catenin

Foscenvivint

RCM-1

LF3

Tegatrabetan

MSAB

p53

Nutlin-3a

Pifithrin-α (PFTα) HBr

SAR405838

Eprenetapopt

Pifithrin-μ

MUC16

Sofituzumab vedotin

Oregovomab

Abagovomab

Sofituzumab

FGFR2

NSC12

SKLB 610

Alofanib

Pemigatinib

ASP5878

PBRM1

ACBI1

Anti-Angiogenesis (B)

VDA

Verteporfin

Vadimezan

Plinabulin

TIE2

Regorafenib

Tie2 kinase inhibitor 1

Pexmetinib

MGCD-265 analog

Angiotensin

Angiotensin II human Acetate

Angiotensin

Azilsartan

Olmesartan

TKIs

EGFR

Osimertinib

Afatinib

Gefitinib

Lapatinib

Erlotinib

VEGFR

Lenvatinib

Regorafenib

Cabozantinib malate

Axitinib

Lenvatinib Mesylate

c-Met

Cabozantinib

Crizotinib

Capmatinib

Foretinib

SGX-523

PDGFR

Sorafenib

Ponatinib

Sunitinib

Imatinib

Linifanib

c-Kit

Dasatinib

Imatinib

Sorafenib tosylate

Sunitinib

Regorafenib

PI3K/Akt/mTOR

Akt

MK-2206 2HCl

Perifosine

Capivasertib

SC79

GSK690693

PI3K

LY294002

3-MA

Dactolisib

Pictilisib

Wortmannin

mTOR

Rapamycin

Everolimus

Dactolisib

AZD8055

NU7441

AMPK

Nilotinib

GSK690693

Doxorubicin (DOX) HCl

AICAR

Phenformin HCl

DNA-PK

Nedisertib

T0070907

Samotolisib

Torin 2

PP121

MAPK

Ras

Zoledronic acid

Sotorasib

Lonafarnib

ARS-1620

Zoledronic acid monohydrate

ERK

Bortezomib

SCH772984

Bosutinib

BIX 02189

Resveratrol

Raf

Vemurafenib

Sorafenib

Sorafenib tosylate

Dabrafenib

Regorafenib

MEK

Trametinib

Mirdametinib

U0126-EtOH

Selumetinib

PD98059

JNK

SP600125

Doramapimod

JNK-IN-8

Metformin HCl

Anisomycin

Cell Cycle

Rho

Rhosin hydrochloride

Zoledronic acid

Fasudil HCl

NSC 23766 trihydrochloride

ML141

p21

Dacinostat

APTO-253

Ailanthone

GC7 Sulfate

UC2288

CDK

Palbociclib (PD-0332991) HCl

Dinaciclib

Ro-3306

Roscovitine

PF-562271

DNA/RNA Synthesis

PF-562271

Cisplatin

Gemcitabine

5-FU

Cycloheximide

Chk

Oxaliplatin

AZD7762

Rabusertib

MK-8776

CHIR-124

Prexasertib HCl

mAb & ADC

EGFR

Cetuximab

Panitumumab

Cetuximab-MMAE

Serclutamab talirine

Laprituximab emtansine

Depatuxizumab mafodotin

Disitamab vedotin

VEGFR

Bevacizumab

Ramucirumab

MUC16

Sofituzumab vedotin

Oregovomab

Abagovomab

Sofituzumab

GPC3

Codrituzumab

Codrituzumab-MMAE

PD-1

Pembrolizumab

Dostarlimab

Cemiplimab

Camrelizumab

Sintilimab

Nivolumab

Serplulimab

PD-L1

Atezolizumab

Durvalumab

Avelumab

Adebrelimab

Sugemalimab

CTLA-4

Nurulimab

Zalifrelimab

Quavonlimab

Ipilimumab

Tremelimumab

Compound Library